Bausch + Lomb Corporation (BLCO)

USD 18.24

(-3.24%)

Total Liabilities Summary of Bausch + Lomb Corporation

  • Bausch + Lomb Corporation's latest annual total liabilities in 2023 was 6.52 Billion USD , up 61.32% from previous year.
  • Bausch + Lomb Corporation's latest quarterly total liabilities in 2024 Q3 was 6.85 Billion USD , up 2.76% from previous quarter.
  • Bausch + Lomb Corporation reported annual total liabilities of 4.04 Billion USD in 2022, up 184.52% from previous year.
  • Bausch + Lomb Corporation reported annual total liabilities of 1.42 Billion USD in 2021, up 11.19% from previous year.
  • Bausch + Lomb Corporation reported quarterly total liabilities of 6.67 Billion USD for 2024 Q2, up 1.61% from previous quarter.
  • Bausch + Lomb Corporation reported quarterly total liabilities of 6.56 Billion USD for 2024 Q1, up 0.64% from previous quarter.

Annual Total Liabilities Chart of Bausch + Lomb Corporation (2023 - 2019)

Historical Annual Total Liabilities of Bausch + Lomb Corporation (2023 - 2019)

Year Total Liabilities Total Liabilities Growth
2023 6.52 Billion USD 61.32%
2022 4.04 Billion USD 184.52%
2021 1.42 Billion USD 11.19%
2020 1.27 Billion USD -11.0%
2019 1.43 Billion USD 0.0%

Peer Total Liabilities Comparison of Bausch + Lomb Corporation

Name Total Liabilities Total Liabilities Difference
Alcon Inc. 8.98 Billion USD 27.428%
AptarGroup, Inc. 2.13 Billion USD -206.112%
Baxter International Inc. 19.8 Billion USD 67.074%
Becton, Dickinson and Company 26.98 Billion USD 75.83%
Haemonetics Corporation 1.23 Billion USD -427.827%
Envista Holdings Corp 2.43 Billion USD -168.263%
ResMed Inc. 2 Billion USD -224.744%
Teleflex Incorporated 3.09 Billion USD -110.962%
Warby Parker Inc. 278.52 Million USD -2241.621%
West Pharmaceutical Services, Inc. 948.5 Million USD -587.612%